nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Diplopia—Capecitabine—stomach cancer	0.00347	0.00409	CcSEcCtD
Pentazocine—Visual impairment—Irinotecan—stomach cancer	0.00346	0.00408	CcSEcCtD
Pentazocine—Face oedema—Capecitabine—stomach cancer	0.00335	0.00395	CcSEcCtD
Pentazocine—Flushing—Irinotecan—stomach cancer	0.00333	0.00392	CcSEcCtD
Pentazocine—Irritability—Capecitabine—stomach cancer	0.00332	0.00391	CcSEcCtD
Pentazocine—Urinary retention—Capecitabine—stomach cancer	0.0033	0.00389	CcSEcCtD
Pentazocine—Ulcer—Doxorubicin—stomach cancer	0.00326	0.00384	CcSEcCtD
Pentazocine—Cramp muscle—Docetaxel—stomach cancer	0.00323	0.00381	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.00323	0.00381	CcSEcCtD
Pentazocine—Chills—Irinotecan—stomach cancer	0.00322	0.00379	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.00313	0.00368	CcSEcCtD
Pentazocine—Muscle spasms—Irinotecan—stomach cancer	0.00301	0.00354	CcSEcCtD
Pentazocine—Sweating increased—Capecitabine—stomach cancer	0.00293	0.00344	CcSEcCtD
Pentazocine—Abdominal discomfort—Capecitabine—stomach cancer	0.00288	0.00339	CcSEcCtD
Pentazocine—Vision blurred—Fluorouracil—stomach cancer	0.00282	0.00332	CcSEcCtD
Pentazocine—Vertigo—Irinotecan—stomach cancer	0.00281	0.00331	CcSEcCtD
Pentazocine—Syncope—Irinotecan—stomach cancer	0.0028	0.0033	CcSEcCtD
Pentazocine—Hepatic function abnormal—Epirubicin—stomach cancer	0.00277	0.00326	CcSEcCtD
Pentazocine—Loss of consciousness—Irinotecan—stomach cancer	0.00275	0.00324	CcSEcCtD
Pentazocine—Visual disturbance—Methotrexate—stomach cancer	0.00273	0.00321	CcSEcCtD
Pentazocine—Hypertension—Irinotecan—stomach cancer	0.0027	0.00318	CcSEcCtD
Pentazocine—Agranulocytosis—Docetaxel—stomach cancer	0.00258	0.00304	CcSEcCtD
Pentazocine—Confusional state—Irinotecan—stomach cancer	0.00257	0.00303	CcSEcCtD
Pentazocine—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00256	0.00302	CcSEcCtD
Pentazocine—Anaphylactic shock—Irinotecan—stomach cancer	0.00255	0.003	CcSEcCtD
Pentazocine—Shock—Irinotecan—stomach cancer	0.00251	0.00296	CcSEcCtD
Pentazocine—Agranulocytosis—Capecitabine—stomach cancer	0.0025	0.00294	CcSEcCtD
Pentazocine—Irritability—Methotrexate—stomach cancer	0.00247	0.00291	CcSEcCtD
Pentazocine—Hyperhidrosis—Irinotecan—stomach cancer	0.00247	0.0029	CcSEcCtD
Pentazocine—Confusional state—Fluorouracil—stomach cancer	0.00246	0.0029	CcSEcCtD
Pentazocine—Anaphylactic shock—Fluorouracil—stomach cancer	0.00244	0.00288	CcSEcCtD
Pentazocine—Anorexia—Irinotecan—stomach cancer	0.00243	0.00286	CcSEcCtD
Pentazocine—Diplopia—Epirubicin—stomach cancer	0.00242	0.00285	CcSEcCtD
Pentazocine—Visual impairment—Docetaxel—stomach cancer	0.00239	0.00282	CcSEcCtD
Pentazocine—Tachycardia—Fluorouracil—stomach cancer	0.00239	0.00281	CcSEcCtD
Pentazocine—Hypotension—Irinotecan—stomach cancer	0.00238	0.00281	CcSEcCtD
Pentazocine—Erythema multiforme—Docetaxel—stomach cancer	0.00235	0.00276	CcSEcCtD
Pentazocine—Face oedema—Epirubicin—stomach cancer	0.00234	0.00275	CcSEcCtD
Pentazocine—Anorexia—Fluorouracil—stomach cancer	0.00233	0.00274	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.00233	0.00274	CcSEcCtD
Pentazocine—Visual impairment—Capecitabine—stomach cancer	0.00232	0.00273	CcSEcCtD
Pentazocine—Insomnia—Irinotecan—stomach cancer	0.00231	0.00272	CcSEcCtD
Pentazocine—Flushing—Docetaxel—stomach cancer	0.0023	0.00271	CcSEcCtD
Pentazocine—Paraesthesia—Irinotecan—stomach cancer	0.00229	0.0027	CcSEcCtD
Pentazocine—Hypotension—Fluorouracil—stomach cancer	0.00228	0.00269	CcSEcCtD
Pentazocine—Dyspnoea—Irinotecan—stomach cancer	0.00228	0.00268	CcSEcCtD
Pentazocine—Erythema multiforme—Capecitabine—stomach cancer	0.00227	0.00268	CcSEcCtD
Pentazocine—Somnolence—Irinotecan—stomach cancer	0.00227	0.00267	CcSEcCtD
Pentazocine—Tinnitus—Capecitabine—stomach cancer	0.00224	0.00264	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—stomach cancer	0.00224	0.00264	CcSEcCtD
Pentazocine—Flushing—Capecitabine—stomach cancer	0.00223	0.00263	CcSEcCtD
Pentazocine—Chills—Docetaxel—stomach cancer	0.00223	0.00262	CcSEcCtD
Pentazocine—Decreased appetite—Irinotecan—stomach cancer	0.00222	0.00261	CcSEcCtD
Pentazocine—Eosinophilia—Methotrexate—stomach cancer	0.00221	0.00261	CcSEcCtD
Pentazocine—Insomnia—Fluorouracil—stomach cancer	0.00221	0.0026	CcSEcCtD
Pentazocine—Paraesthesia—Fluorouracil—stomach cancer	0.00219	0.00258	CcSEcCtD
Pentazocine—Constipation—Irinotecan—stomach cancer	0.00218	0.00257	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.00218	0.00257	CcSEcCtD
Pentazocine—Dyspnoea—Fluorouracil—stomach cancer	0.00218	0.00257	CcSEcCtD
Pentazocine—Somnolence—Fluorouracil—stomach cancer	0.00217	0.00256	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—stomach cancer	0.00216	0.00255	CcSEcCtD
Pentazocine—Chills—Capecitabine—stomach cancer	0.00216	0.00254	CcSEcCtD
Pentazocine—Abdominal discomfort—Methotrexate—stomach cancer	0.00214	0.00252	CcSEcCtD
Pentazocine—Decreased appetite—Fluorouracil—stomach cancer	0.00212	0.0025	CcSEcCtD
Pentazocine—Dysgeusia—Docetaxel—stomach cancer	0.00212	0.00249	CcSEcCtD
Pentazocine—Feeling abnormal—Irinotecan—stomach cancer	0.0021	0.00248	CcSEcCtD
Pentazocine—Muscle spasms—Docetaxel—stomach cancer	0.00208	0.00245	CcSEcCtD
Pentazocine—Eosinophilia—Epirubicin—stomach cancer	0.00207	0.00244	CcSEcCtD
Pentazocine—Dysgeusia—Capecitabine—stomach cancer	0.00205	0.00241	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.00202	0.00237	CcSEcCtD
Pentazocine—Feeling abnormal—Fluorouracil—stomach cancer	0.00201	0.00237	CcSEcCtD
Pentazocine—Muscle spasms—Capecitabine—stomach cancer	0.00201	0.00237	CcSEcCtD
Pentazocine—Vision blurred—Capecitabine—stomach cancer	0.00197	0.00232	CcSEcCtD
Pentazocine—Tremor—Capecitabine—stomach cancer	0.00196	0.00231	CcSEcCtD
Pentazocine—Syncope—Docetaxel—stomach cancer	0.00194	0.00228	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—stomach cancer	0.00192	0.00226	CcSEcCtD
Pentazocine—Sweating—Methotrexate—stomach cancer	0.00191	0.00225	CcSEcCtD
Pentazocine—Loss of consciousness—Docetaxel—stomach cancer	0.0019	0.00224	CcSEcCtD
Pentazocine—Vertigo—Capecitabine—stomach cancer	0.00188	0.00221	CcSEcCtD
Pentazocine—Hypersensitivity—Irinotecan—stomach cancer	0.00188	0.00221	CcSEcCtD
Pentazocine—Syncope—Capecitabine—stomach cancer	0.00188	0.00221	CcSEcCtD
Pentazocine—Hypertension—Docetaxel—stomach cancer	0.00187	0.0022	CcSEcCtD
Pentazocine—Agranulocytosis—Methotrexate—stomach cancer	0.00186	0.00219	CcSEcCtD
Pentazocine—Loss of consciousness—Capecitabine—stomach cancer	0.00184	0.00217	CcSEcCtD
Pentazocine—Asthenia—Irinotecan—stomach cancer	0.00183	0.00216	CcSEcCtD
Pentazocine—Hypertension—Capecitabine—stomach cancer	0.00181	0.00213	CcSEcCtD
Pentazocine—Hypersensitivity—Fluorouracil—stomach cancer	0.0018	0.00212	CcSEcCtD
Pentazocine—Dry mouth—Docetaxel—stomach cancer	0.0018	0.00212	CcSEcCtD
Pentazocine—Sweating—Epirubicin—stomach cancer	0.00179	0.00211	CcSEcCtD
Pentazocine—Confusional state—Docetaxel—stomach cancer	0.00178	0.00209	CcSEcCtD
Pentazocine—Anaphylactic shock—Docetaxel—stomach cancer	0.00176	0.00208	CcSEcCtD
Pentazocine—Diarrhoea—Irinotecan—stomach cancer	0.00175	0.00206	CcSEcCtD
Pentazocine—Dry mouth—Capecitabine—stomach cancer	0.00174	0.00205	CcSEcCtD
Pentazocine—Agranulocytosis—Epirubicin—stomach cancer	0.00174	0.00205	CcSEcCtD
Pentazocine—Shock—Docetaxel—stomach cancer	0.00174	0.00204	CcSEcCtD
Pentazocine—Pruritus—Fluorouracil—stomach cancer	0.00173	0.00204	CcSEcCtD
Pentazocine—Visual impairment—Methotrexate—stomach cancer	0.00172	0.00203	CcSEcCtD
Pentazocine—Confusional state—Capecitabine—stomach cancer	0.00172	0.00203	CcSEcCtD
Pentazocine—Tachycardia—Docetaxel—stomach cancer	0.00172	0.00203	CcSEcCtD
Pentazocine—Erythema multiforme—Methotrexate—stomach cancer	0.00169	0.00199	CcSEcCtD
Pentazocine—Dizziness—Irinotecan—stomach cancer	0.00169	0.00199	CcSEcCtD
Pentazocine—Anorexia—Docetaxel—stomach cancer	0.00168	0.00198	CcSEcCtD
Pentazocine—Shock—Capecitabine—stomach cancer	0.00168	0.00198	CcSEcCtD
Pentazocine—Diarrhoea—Fluorouracil—stomach cancer	0.00167	0.00197	CcSEcCtD
Pentazocine—Tinnitus—Methotrexate—stomach cancer	0.00167	0.00196	CcSEcCtD
Pentazocine—Tachycardia—Capecitabine—stomach cancer	0.00167	0.00196	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—stomach cancer	0.00165	0.00195	CcSEcCtD
Pentazocine—Hyperhidrosis—Capecitabine—stomach cancer	0.00165	0.00194	CcSEcCtD
Pentazocine—Hypotension—Docetaxel—stomach cancer	0.00165	0.00194	CcSEcCtD
Pentazocine—Anorexia—Capecitabine—stomach cancer	0.00163	0.00192	CcSEcCtD
Pentazocine—Vomiting—Irinotecan—stomach cancer	0.00162	0.00191	CcSEcCtD
Pentazocine—Dizziness—Fluorouracil—stomach cancer	0.00162	0.0019	CcSEcCtD
Pentazocine—Visual impairment—Epirubicin—stomach cancer	0.00161	0.0019	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—stomach cancer	0.00161	0.0019	CcSEcCtD
Pentazocine—Dermatitis—Irinotecan—stomach cancer	0.00161	0.00189	CcSEcCtD
Pentazocine—Chills—Methotrexate—stomach cancer	0.00161	0.00189	CcSEcCtD
Pentazocine—Headache—Irinotecan—stomach cancer	0.0016	0.00188	CcSEcCtD
Pentazocine—Hypotension—Capecitabine—stomach cancer	0.0016	0.00188	CcSEcCtD
Pentazocine—Insomnia—Docetaxel—stomach cancer	0.0016	0.00188	CcSEcCtD
Pentazocine—Paraesthesia—Docetaxel—stomach cancer	0.00158	0.00187	CcSEcCtD
Pentazocine—Erythema multiforme—Epirubicin—stomach cancer	0.00158	0.00186	CcSEcCtD
Pentazocine—Dyspnoea—Docetaxel—stomach cancer	0.00157	0.00185	CcSEcCtD
Pentazocine—Somnolence—Docetaxel—stomach cancer	0.00157	0.00185	CcSEcCtD
Pentazocine—Tinnitus—Epirubicin—stomach cancer	0.00156	0.00184	CcSEcCtD
Pentazocine—Flushing—Epirubicin—stomach cancer	0.00155	0.00183	CcSEcCtD
Pentazocine—Vomiting—Fluorouracil—stomach cancer	0.00155	0.00183	CcSEcCtD
Pentazocine—Insomnia—Capecitabine—stomach cancer	0.00154	0.00182	CcSEcCtD
Pentazocine—Dermatitis—Fluorouracil—stomach cancer	0.00154	0.00181	CcSEcCtD
Pentazocine—Paraesthesia—Capecitabine—stomach cancer	0.00153	0.00181	CcSEcCtD
Pentazocine—Decreased appetite—Docetaxel—stomach cancer	0.00153	0.00181	CcSEcCtD
Pentazocine—Headache—Fluorouracil—stomach cancer	0.00153	0.0018	CcSEcCtD
Pentazocine—Dysgeusia—Methotrexate—stomach cancer	0.00153	0.0018	CcSEcCtD
Pentazocine—Dyspnoea—Capecitabine—stomach cancer	0.00152	0.00179	CcSEcCtD
Pentazocine—Nausea—Irinotecan—stomach cancer	0.00152	0.00178	CcSEcCtD
Pentazocine—Constipation—Docetaxel—stomach cancer	0.00151	0.00178	CcSEcCtD
Pentazocine—Chills—Epirubicin—stomach cancer	0.0015	0.00177	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—stomach cancer	0.00149	0.00176	CcSEcCtD
Pentazocine—Decreased appetite—Capecitabine—stomach cancer	0.00148	0.00175	CcSEcCtD
Pentazocine—Vision blurred—Methotrexate—stomach cancer	0.00147	0.00173	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—stomach cancer	0.00147	0.00173	CcSEcCtD
Pentazocine—Constipation—Capecitabine—stomach cancer	0.00146	0.00172	CcSEcCtD
Pentazocine—Feeling abnormal—Docetaxel—stomach cancer	0.00145	0.00171	CcSEcCtD
Pentazocine—Nausea—Fluorouracil—stomach cancer	0.00145	0.00171	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—stomach cancer	0.00144	0.0017	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—stomach cancer	0.00144	0.00169	CcSEcCtD
Pentazocine—Dysgeusia—Epirubicin—stomach cancer	0.00143	0.00168	CcSEcCtD
Pentazocine—Feeling abnormal—Capecitabine—stomach cancer	0.00141	0.00166	CcSEcCtD
Pentazocine—Muscle spasms—Epirubicin—stomach cancer	0.0014	0.00165	CcSEcCtD
Pentazocine—Vertigo—Methotrexate—stomach cancer	0.0014	0.00165	CcSEcCtD
Pentazocine—Chills—Doxorubicin—stomach cancer	0.00139	0.00164	CcSEcCtD
Pentazocine—Vision blurred—Epirubicin—stomach cancer	0.00137	0.00162	CcSEcCtD
Pentazocine—Agitation—Epirubicin—stomach cancer	0.00134	0.00158	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—stomach cancer	0.00132	0.00156	CcSEcCtD
Pentazocine—Vertigo—Epirubicin—stomach cancer	0.00131	0.00154	CcSEcCtD
Pentazocine—Syncope—Epirubicin—stomach cancer	0.00131	0.00154	CcSEcCtD
Pentazocine—Hypersensitivity—Docetaxel—stomach cancer	0.0013	0.00153	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—stomach cancer	0.0013	0.00153	CcSEcCtD
Pentazocine—Confusional state—Methotrexate—stomach cancer	0.00128	0.00151	CcSEcCtD
Pentazocine—Loss of consciousness—Epirubicin—stomach cancer	0.00128	0.00151	CcSEcCtD
Pentazocine—Anaphylactic shock—Methotrexate—stomach cancer	0.00127	0.0015	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—stomach cancer	0.00127	0.0015	CcSEcCtD
Pentazocine—Asthenia—Docetaxel—stomach cancer	0.00127	0.00149	CcSEcCtD
Pentazocine—Hypertension—Epirubicin—stomach cancer	0.00126	0.00148	CcSEcCtD
Pentazocine—Hypersensitivity—Capecitabine—stomach cancer	0.00126	0.00148	CcSEcCtD
Pentazocine—Pruritus—Docetaxel—stomach cancer	0.00125	0.00147	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—stomach cancer	0.00124	0.00146	CcSEcCtD
Pentazocine—Hyperhidrosis—Methotrexate—stomach cancer	0.00123	0.00145	CcSEcCtD
Pentazocine—Asthenia—Capecitabine—stomach cancer	0.00123	0.00144	CcSEcCtD
Pentazocine—Dry mouth—Epirubicin—stomach cancer	0.00121	0.00143	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—stomach cancer	0.00121	0.00143	CcSEcCtD
Pentazocine—Anorexia—Methotrexate—stomach cancer	0.00121	0.00143	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—stomach cancer	0.00121	0.00142	CcSEcCtD
Pentazocine—Pruritus—Capecitabine—stomach cancer	0.00121	0.00142	CcSEcCtD
Pentazocine—Diarrhoea—Docetaxel—stomach cancer	0.00121	0.00142	CcSEcCtD
Pentazocine—Confusional state—Epirubicin—stomach cancer	0.0012	0.00141	CcSEcCtD
Pentazocine—Anaphylactic shock—Epirubicin—stomach cancer	0.00119	0.0014	CcSEcCtD
Pentazocine—Hypotension—Methotrexate—stomach cancer	0.00119	0.0014	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—stomach cancer	0.00119	0.0014	CcSEcCtD
Pentazocine—Shock—Epirubicin—stomach cancer	0.00117	0.00138	CcSEcCtD
Pentazocine—Diarrhoea—Capecitabine—stomach cancer	0.00117	0.00138	CcSEcCtD
Pentazocine—Dizziness—Docetaxel—stomach cancer	0.00117	0.00137	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—stomach cancer	0.00116	0.00137	CcSEcCtD
Pentazocine—Tachycardia—Epirubicin—stomach cancer	0.00116	0.00137	CcSEcCtD
Pentazocine—Hyperhidrosis—Epirubicin—stomach cancer	0.00115	0.00135	CcSEcCtD
Pentazocine—Insomnia—Methotrexate—stomach cancer	0.00115	0.00135	CcSEcCtD
Pentazocine—Paraesthesia—Methotrexate—stomach cancer	0.00114	0.00134	CcSEcCtD
Pentazocine—Anorexia—Epirubicin—stomach cancer	0.00113	0.00134	CcSEcCtD
Pentazocine—Dyspnoea—Methotrexate—stomach cancer	0.00113	0.00133	CcSEcCtD
Pentazocine—Somnolence—Methotrexate—stomach cancer	0.00113	0.00133	CcSEcCtD
Pentazocine—Dizziness—Capecitabine—stomach cancer	0.00113	0.00133	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—stomach cancer	0.00112	0.00132	CcSEcCtD
Pentazocine—Vomiting—Docetaxel—stomach cancer	0.00112	0.00132	CcSEcCtD
Pentazocine—Hypotension—Epirubicin—stomach cancer	0.00111	0.00131	CcSEcCtD
Pentazocine—Dermatitis—Docetaxel—stomach cancer	0.00111	0.00131	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—stomach cancer	0.00111	0.00131	CcSEcCtD
Pentazocine—Decreased appetite—Methotrexate—stomach cancer	0.00111	0.0013	CcSEcCtD
Pentazocine—Headache—Docetaxel—stomach cancer	0.00111	0.0013	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—stomach cancer	0.0011	0.0013	CcSEcCtD
Pentazocine—Vomiting—Capecitabine—stomach cancer	0.00109	0.00128	CcSEcCtD
Pentazocine—Shock—Doxorubicin—stomach cancer	0.00108	0.00128	CcSEcCtD
Pentazocine—Insomnia—Epirubicin—stomach cancer	0.00108	0.00127	CcSEcCtD
Pentazocine—Dermatitis—Capecitabine—stomach cancer	0.00108	0.00127	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—stomach cancer	0.00107	0.00127	CcSEcCtD
Pentazocine—Headache—Capecitabine—stomach cancer	0.00107	0.00126	CcSEcCtD
Pentazocine—Paraesthesia—Epirubicin—stomach cancer	0.00107	0.00126	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—stomach cancer	0.00106	0.00125	CcSEcCtD
Pentazocine—Dyspnoea—Epirubicin—stomach cancer	0.00106	0.00125	CcSEcCtD
Pentazocine—Somnolence—Epirubicin—stomach cancer	0.00106	0.00125	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—stomach cancer	0.00105	0.00124	CcSEcCtD
Pentazocine—Nausea—Docetaxel—stomach cancer	0.00105	0.00123	CcSEcCtD
Pentazocine—Feeling abnormal—Methotrexate—stomach cancer	0.00105	0.00123	CcSEcCtD
Pentazocine—Decreased appetite—Epirubicin—stomach cancer	0.00103	0.00122	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—stomach cancer	0.00103	0.00121	CcSEcCtD
Pentazocine—Constipation—Epirubicin—stomach cancer	0.00102	0.0012	CcSEcCtD
Pentazocine—Nausea—Capecitabine—stomach cancer	0.00101	0.00119	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—stomach cancer	0.000996	0.00117	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—stomach cancer	0.000989	0.00116	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—stomach cancer	0.000982	0.00116	CcSEcCtD
Pentazocine—Feeling abnormal—Epirubicin—stomach cancer	0.00098	0.00115	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—stomach cancer	0.000979	0.00115	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—stomach cancer	0.000957	0.00113	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—stomach cancer	0.000941	0.00111	CcSEcCtD
Pentazocine—Hypersensitivity—Methotrexate—stomach cancer	0.000937	0.0011	CcSEcCtD
Pentazocine—Asthenia—Methotrexate—stomach cancer	0.000912	0.00107	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—stomach cancer	0.000907	0.00107	CcSEcCtD
Pentazocine—Pruritus—Methotrexate—stomach cancer	0.0009	0.00106	CcSEcCtD
Pentazocine—Hypersensitivity—Epirubicin—stomach cancer	0.000877	0.00103	CcSEcCtD
Pentazocine—Diarrhoea—Methotrexate—stomach cancer	0.00087	0.00102	CcSEcCtD
Pentazocine—Asthenia—Epirubicin—stomach cancer	0.000854	0.00101	CcSEcCtD
Pentazocine—Pruritus—Epirubicin—stomach cancer	0.000842	0.000991	CcSEcCtD
Pentazocine—Dizziness—Methotrexate—stomach cancer	0.000841	0.00099	CcSEcCtD
Pentazocine—Diarrhoea—Epirubicin—stomach cancer	0.000814	0.000959	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—stomach cancer	0.000811	0.000955	CcSEcCtD
Pentazocine—Vomiting—Methotrexate—stomach cancer	0.000808	0.000952	CcSEcCtD
Pentazocine—Dermatitis—Methotrexate—stomach cancer	0.000801	0.000943	CcSEcCtD
Pentazocine—Headache—Methotrexate—stomach cancer	0.000796	0.000938	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—stomach cancer	0.00079	0.00093	CcSEcCtD
Pentazocine—Dizziness—Epirubicin—stomach cancer	0.000787	0.000926	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—stomach cancer	0.000779	0.000917	CcSEcCtD
Pentazocine—Vomiting—Epirubicin—stomach cancer	0.000757	0.000891	CcSEcCtD
Pentazocine—Nausea—Methotrexate—stomach cancer	0.000755	0.000889	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—stomach cancer	0.000753	0.000887	CcSEcCtD
Pentazocine—Dermatitis—Epirubicin—stomach cancer	0.00075	0.000882	CcSEcCtD
Pentazocine—Headache—Epirubicin—stomach cancer	0.000745	0.000878	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—stomach cancer	0.000728	0.000857	CcSEcCtD
Pentazocine—Nausea—Epirubicin—stomach cancer	0.000707	0.000832	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—stomach cancer	0.0007	0.000824	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—stomach cancer	0.000694	0.000817	CcSEcCtD
Pentazocine—Headache—Doxorubicin—stomach cancer	0.00069	0.000812	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—stomach cancer	0.000654	0.00077	CcSEcCtD
Pentazocine—OPRD1—Signaling by GPCR—ADRB1—stomach cancer	0.000185	0.00123	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ANXA1—stomach cancer	0.000185	0.00123	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRH4—stomach cancer	0.000184	0.00122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—WIF1—stomach cancer	0.000184	0.00122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGTR2—stomach cancer	0.000181	0.0012	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRB1—stomach cancer	0.000179	0.00119	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—F2R—stomach cancer	0.000179	0.00119	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR1A—stomach cancer	0.000174	0.00115	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCL8—stomach cancer	0.000173	0.00115	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PPARG—stomach cancer	0.000172	0.00114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKAB1—stomach cancer	0.00017	0.00112	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGTR2—stomach cancer	0.000168	0.00112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ANXA1—stomach cancer	0.000168	0.00111	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—WWOX—stomach cancer	0.000167	0.00111	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FST—stomach cancer	0.000166	0.0011	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—F2R—stomach cancer	0.000166	0.0011	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—ADRB2—stomach cancer	0.000165	0.0011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RNF43—stomach cancer	0.000164	0.00109	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KISS1—stomach cancer	0.000164	0.00109	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000163	0.00108	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HBEGF—stomach cancer	0.000163	0.00108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRB1—stomach cancer	0.000163	0.00108	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR1A—stomach cancer	0.000162	0.00107	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RGS2—stomach cancer	0.000161	0.00107	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GAST—stomach cancer	0.000161	0.00107	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ANXA1—stomach cancer	0.000156	0.00104	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRH4—stomach cancer	0.000155	0.00103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—WIF1—stomach cancer	0.000155	0.00103	CbGpPWpGaD
Pentazocine—EBP—Metabolism—ALB—stomach cancer	0.000155	0.00103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGTR2—stomach cancer	0.000153	0.00101	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGG—stomach cancer	0.000152	0.00101	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRB1—stomach cancer	0.000151	0.001	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—F2R—stomach cancer	0.000151	0.001	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ADRB2—stomach cancer	0.00015	0.000997	CbGpPWpGaD
Pentazocine—EBP—Metabolism—NOS3—stomach cancer	0.000148	0.000982	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000147	0.000977	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR1A—stomach cancer	0.000147	0.000975	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKAA1—stomach cancer	0.000147	0.000972	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FST—stomach cancer	0.000146	0.000968	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRB2—stomach cancer	0.000145	0.000963	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKAB1—stomach cancer	0.000143	0.000951	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HBEGF—stomach cancer	0.000143	0.000947	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ANXA1—stomach cancer	0.000142	0.000942	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RBP4—stomach cancer	0.000141	0.000939	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL8—stomach cancer	0.000141	0.000938	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GAST—stomach cancer	0.000141	0.000934	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RGS2—stomach cancer	0.000141	0.000934	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KISS1—stomach cancer	0.000138	0.000918	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RNF43—stomach cancer	0.000138	0.000918	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000138	0.000913	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRB1—stomach cancer	0.000137	0.000912	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PTGS2—stomach cancer	0.000135	0.000899	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGG—stomach cancer	0.000133	0.000886	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRB2—stomach cancer	0.000132	0.000874	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000129	0.000857	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKAA1—stomach cancer	0.000128	0.000853	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RBP4—stomach cancer	0.000124	0.000823	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL8—stomach cancer	0.000124	0.000823	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FST—stomach cancer	0.000123	0.000818	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRB2—stomach cancer	0.000123	0.000814	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HSPB1—stomach cancer	0.000122	0.000807	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGTR2—stomach cancer	0.000122	0.000807	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HBEGF—stomach cancer	0.000121	0.000801	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BMP2—stomach cancer	0.00012	0.000798	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—F2R—stomach cancer	0.00012	0.000798	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RGS2—stomach cancer	0.000119	0.00079	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAST—stomach cancer	0.000119	0.00079	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKR1C3—stomach cancer	0.000118	0.000785	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR1A—stomach cancer	0.000117	0.000777	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PRKCB—stomach cancer	0.000113	0.000753	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ANXA1—stomach cancer	0.000113	0.000751	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGG—stomach cancer	0.000113	0.000749	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRB2—stomach cancer	0.000111	0.000739	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB1—stomach cancer	0.00011	0.000727	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000109	0.000724	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKAA1—stomach cancer	0.000109	0.000721	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGTR2—stomach cancer	0.000107	0.000708	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HSPB1—stomach cancer	0.000107	0.000708	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—F2R—stomach cancer	0.000105	0.0007	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BMP2—stomach cancer	0.000105	0.0007	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RBP4—stomach cancer	0.000105	0.000696	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL8—stomach cancer	0.000105	0.000695	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RPS6—stomach cancer	0.000105	0.000695	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKR1C3—stomach cancer	0.000104	0.000689	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PRKCB—stomach cancer	0.000103	0.000683	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR1A—stomach cancer	0.000103	0.000682	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6ST—stomach cancer	0.000103	0.000681	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PRKCB—stomach cancer	9.94e-05	0.00066	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ANXA1—stomach cancer	9.92e-05	0.000658	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HBEGF—stomach cancer	9.62e-05	0.000638	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB1—stomach cancer	9.61e-05	0.000637	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RPS6—stomach cancer	9.18e-05	0.000609	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6R—stomach cancer	9.15e-05	0.000607	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—RHOA—stomach cancer	9.1e-05	0.000604	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PRKCB—stomach cancer	9.03e-05	0.000599	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HSPB1—stomach cancer	9.02e-05	0.000598	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGTR2—stomach cancer	9.02e-05	0.000598	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6ST—stomach cancer	8.99e-05	0.000597	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BMP2—stomach cancer	8.92e-05	0.000592	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—F2R—stomach cancer	8.92e-05	0.000592	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB2—stomach cancer	8.88e-05	0.000589	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKR1C3—stomach cancer	8.77e-05	0.000582	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PPP2R1A—stomach cancer	8.7e-05	0.000577	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR1A—stomach cancer	8.68e-05	0.000576	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HBEGF—stomach cancer	8.43e-05	0.00056	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PRKCB—stomach cancer	8.4e-05	0.000558	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ANXA1—stomach cancer	8.38e-05	0.000556	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CA—stomach cancer	8.33e-05	0.000553	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—RHOA—stomach cancer	8.27e-05	0.000549	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB1—stomach cancer	8.12e-05	0.000539	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SMAD4—stomach cancer	8.08e-05	0.000536	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6R—stomach cancer	8.02e-05	0.000533	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—stomach cancer	7.99e-05	0.00053	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—RHOA—stomach cancer	7.98e-05	0.00053	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB2—stomach cancer	7.78e-05	0.000517	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RPS6—stomach cancer	7.76e-05	0.000515	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FYN—stomach cancer	7.67e-05	0.000509	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCB—stomach cancer	7.63e-05	0.000506	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PPP2R1A—stomach cancer	7.63e-05	0.000506	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6ST—stomach cancer	7.6e-05	0.000504	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—stomach cancer	7.26e-05	0.000482	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RHOA—stomach cancer	7.25e-05	0.000481	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGFR2—stomach cancer	7.2e-05	0.000478	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HBEGF—stomach cancer	7.13e-05	0.000473	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SMAD4—stomach cancer	7.08e-05	0.00047	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—stomach cancer	7.01e-05	0.000465	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6R—stomach cancer	6.78e-05	0.00045	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—RHOA—stomach cancer	6.75e-05	0.000448	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FYN—stomach cancer	6.72e-05	0.000446	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IRS2—stomach cancer	6.59e-05	0.000437	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB2—stomach cancer	6.58e-05	0.000437	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PPP2R1A—stomach cancer	6.45e-05	0.000428	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CAV1—stomach cancer	6.39e-05	0.000424	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOA1—stomach cancer	6.38e-05	0.000423	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—stomach cancer	6.36e-05	0.000422	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGFR2—stomach cancer	6.31e-05	0.000419	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RHOA—stomach cancer	6.13e-05	0.000407	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCB—stomach cancer	6.08e-05	0.000404	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6ST—stomach cancer	6.06e-05	0.000402	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SMAD4—stomach cancer	5.99e-05	0.000397	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—stomach cancer	5.92e-05	0.000393	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APC—stomach cancer	5.82e-05	0.000386	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IRS2—stomach cancer	5.78e-05	0.000384	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FYN—stomach cancer	5.68e-05	0.000377	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CAV1—stomach cancer	5.6e-05	0.000372	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOA1—stomach cancer	5.59e-05	0.000371	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK3—stomach cancer	5.58e-05	0.00037	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6R—stomach cancer	5.41e-05	0.000359	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—stomach cancer	5.38e-05	0.000357	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGFR2—stomach cancer	5.33e-05	0.000354	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCB—stomach cancer	5.33e-05	0.000354	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6ST—stomach cancer	5.31e-05	0.000353	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK1—stomach cancer	5.31e-05	0.000352	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—stomach cancer	5.3e-05	0.000352	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APC—stomach cancer	5.11e-05	0.000339	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—stomach cancer	5.07e-05	0.000336	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SERPINE1—stomach cancer	5.06e-05	0.000336	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—KRAS—stomach cancer	5.01e-05	0.000333	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK3—stomach cancer	4.89e-05	0.000324	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IRS2—stomach cancer	4.89e-05	0.000324	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RHOA—stomach cancer	4.88e-05	0.000324	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—stomach cancer	4.83e-05	0.000321	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6R—stomach cancer	4.74e-05	0.000315	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CAV1—stomach cancer	4.74e-05	0.000314	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA1—stomach cancer	4.73e-05	0.000314	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK1—stomach cancer	4.65e-05	0.000309	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—stomach cancer	4.65e-05	0.000309	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—stomach cancer	4.6e-05	0.000305	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB2—stomach cancer	4.52e-05	0.0003	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCB—stomach cancer	4.51e-05	0.000299	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6ST—stomach cancer	4.49e-05	0.000298	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—stomach cancer	4.45e-05	0.000295	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SERPINE1—stomach cancer	4.44e-05	0.000295	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—KRAS—stomach cancer	4.39e-05	0.000292	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APC—stomach cancer	4.31e-05	0.000286	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—stomach cancer	4.29e-05	0.000284	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RHOA—stomach cancer	4.28e-05	0.000284	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HRAS—stomach cancer	4.26e-05	0.000283	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—stomach cancer	4.24e-05	0.000281	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1B—stomach cancer	4.19e-05	0.000278	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK3—stomach cancer	4.13e-05	0.000274	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—stomach cancer	4.08e-05	0.000271	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—stomach cancer	4.04e-05	0.000268	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6R—stomach cancer	4.01e-05	0.000266	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCND1—stomach cancer	3.99e-05	0.000265	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JUN—stomach cancer	3.99e-05	0.000264	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB2—stomach cancer	3.96e-05	0.000263	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK1—stomach cancer	3.93e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—stomach cancer	3.93e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—stomach cancer	3.88e-05	0.000257	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1A—stomach cancer	3.86e-05	0.000256	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK8—stomach cancer	3.77e-05	0.00025	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—stomach cancer	3.76e-05	0.000249	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—stomach cancer	3.76e-05	0.000249	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SERPINE1—stomach cancer	3.75e-05	0.000249	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HRAS—stomach cancer	3.73e-05	0.000248	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—KRAS—stomach cancer	3.71e-05	0.000246	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1B—stomach cancer	3.67e-05	0.000244	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RHOA—stomach cancer	3.62e-05	0.00024	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—stomach cancer	3.58e-05	0.000238	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—stomach cancer	3.57e-05	0.000237	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCND1—stomach cancer	3.5e-05	0.000232	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JUN—stomach cancer	3.49e-05	0.000232	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—stomach cancer	3.48e-05	0.000231	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—stomach cancer	3.45e-05	0.000229	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—stomach cancer	3.41e-05	0.000226	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—stomach cancer	3.4e-05	0.000226	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1A—stomach cancer	3.39e-05	0.000225	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB2—stomach cancer	3.35e-05	0.000222	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK8—stomach cancer	3.31e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK3—stomach cancer	3.29e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—stomach cancer	3.2e-05	0.000213	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—stomach cancer	3.18e-05	0.000211	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HRAS—stomach cancer	3.16e-05	0.000209	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK1—stomach cancer	3.13e-05	0.000208	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—stomach cancer	3.13e-05	0.000208	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1B—stomach cancer	3.1e-05	0.000206	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—stomach cancer	3.05e-05	0.000203	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—stomach cancer	3.02e-05	0.000201	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—stomach cancer	3.02e-05	0.0002	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KRAS—stomach cancer	2.96e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCND1—stomach cancer	2.96e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JUN—stomach cancer	2.95e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK3—stomach cancer	2.89e-05	0.000192	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—stomach cancer	2.87e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1A—stomach cancer	2.86e-05	0.00019	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—stomach cancer	2.81e-05	0.000186	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK8—stomach cancer	2.79e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK1—stomach cancer	2.75e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—stomach cancer	2.75e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—stomach cancer	2.72e-05	0.00018	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—stomach cancer	2.63e-05	0.000175	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KRAS—stomach cancer	2.6e-05	0.000172	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—stomach cancer	2.58e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—stomach cancer	2.55e-05	0.00017	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HRAS—stomach cancer	2.52e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK3—stomach cancer	2.44e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—stomach cancer	2.41e-05	0.00016	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	2.38e-05	0.000158	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—stomach cancer	2.37e-05	0.000158	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK1—stomach cancer	2.32e-05	0.000154	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—stomach cancer	2.32e-05	0.000154	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—stomach cancer	2.31e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRAS—stomach cancer	2.21e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KRAS—stomach cancer	2.19e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—stomach cancer	2.11e-05	0.00014	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	2.02e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—stomach cancer	1.95e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRAS—stomach cancer	1.86e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—stomach cancer	1.78e-05	0.000118	CbGpPWpGaD
